Increased heme oxygenase-1 expression in premature infants with respiratory distress syndrome

Ildikó Farkas1, Zoltán Maróti, Márta Katona

  • 1Department of Pediatrics, University of Szeged, Korányi fasor 14-15, Szeged, H-6720, Hungary. ko.farkas@gmail.com

Insights

Preterm infants with respiratory distress syndrome (RDS) show significantly elevated heme oxygenase-1 (HO-1) expression. This increased HO-1, an enzyme protecting against oxidative stress, correlates with disease severity and lower platelet counts.

Area of Science:

  • Neonatal medicine
  • Biochemistry
  • Pathophysiology

Background:

  • Oxidative stress is implicated in severe illnesses affecting preterm infants.
  • Heme oxygenase-1 (HO-1) is a cytoprotective enzyme against oxygen radical damage.
  • Previous studies established HO-1's role in healthy neonates and asymptomatic preterm infants.

Purpose of the Study:

  • To investigate heme oxygenase-1 (HO-1) expression in preterm infants diagnosed with respiratory distress syndrome (RDS).

Main Methods:

  • Collected blood samples from 28 preterm infants with RDS on days 1, 3, and 5 post-birth.
  • Quantified HO-1 mRNA expression using competitive reverse transcriptase PCR.
  • Performed quantitative blood counts to assess platelet levels.

Main Results:

  • Preterm infants with RDS exhibited an approximate eight-fold increase in HO-1 expression compared to healthy mature and asymptomatic preterm infants.
  • A significant negative association was observed between platelet count and HO-1 expression.
  • HO-1 induction was notably higher in RDS infants with thrombocytopenia.

Conclusions:

  • Respiratory distress syndrome (RDS) in preterm infants is associated with heightened HO-1 expression within the first five days of life.
  • Elevated HO-1 expression aligns with the inflammatory and oxidative nature of RDS in neonates.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Respiratory Assessment: Purpose and Indications01:19

Respiratory Assessment: Purpose and Indications

Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Acute Respiratory Failure-IV01:23

Acute Respiratory Failure-IV

Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...